Drug & intervention

treprostinil

RxCUI 343048

Clinical trials13
Recruiting1
Related conditions8
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…
Background context

Treprostinil

Treprostinil, sold under the brand names Remodulin for infusion, Orenitram for oral, and Tyvaso for inhalation among others, is a vasodilator that is used for the treatment of pulmonary arterial hypertension. Treprostinil was approved for use in the United States in May 2002.

Read on Wikipedia ↗ Wikidata Q3495231 ↗
Background only. Canonical identity remains RxNorm; clinical-trial relationships come from ClinicalTrials.gov.

Clinical trials

13 shown
Early Intervention With Inhaled Treprostinil Among Patients With Exercise-Induced Pulmonary Hypertension (EPIH)NCT07837830 · 2026-09-01
RECRUITING
TREPROSTINIL in Pulmonary Hypertension: Evidence and Clinical TrendsNCT07736846 · 2026-07-01
NOT_YET_RECRUITING
Efficacy and Safety of Treprostinil in Intermediate-Risk Pulmonary Arterial HypertensionNCT07177703 · 2025-10-31
NOT_YET_RECRUITING
A Study to Observe the Safety, Tolerability, and Efficacy of RemodulinNCT06603285 · 2025-10-16
NOT_YET_RECRUITING
A Study of Treprostinil to Treat Interstitial Lung Disease Pulmonary HypertensionNCT05564637 · 2023-03-13
COMPLETED
A Study of Infusion Site Pain After Infusion of Excipients in Participants With Type 1 Diabetes MellitusNCT05067270 · 2021-10-22
COMPLETED
Effects of Treprostinil on Right Ventricular Structure and Function in Patients With Pulmonary Arterial HypertensionNCT03835676 · 2019-05-01
UNKNOWN
Patient Global Impression Questions for Activity-Induced Symptoms in Participants With PAHNCT03888365 · 2019-04-01
COMPLETED
Effect of BIA 5-1058 on the Steady State Pharmacokinetics of TreprostinilNCT04675944 · 2018-02-28
COMPLETED
A Study to Assess the Safety and Efficacy of Treprostinil to Facilitate Liver Transplantation in Patients With Portopulmonary HypertensionNCT01028651 · 2011-01-01
COMPLETED
Transition From Injectable Prostacyclin Medication to Inhaled Prostacyclin MedicationNCT01268553 · 2010-08-01
COMPLETED
Treprostinil Therapy For Patients With Interstitial Lung Disease And Severe Pulmonary Arterial HypertensionNCT00705133 · 2008-07-01
COMPLETED
Safety, Efficacy, and Treatment Satisfaction Switching From Flolan to Remodulin Using the Crono Five Ambulatory Pump in Patients With PAHNCT00439946 · 2007-02-01
TERMINATED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.